International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2025

Short Course

Tuesday 13 May | 13:00 – 17:00 (ET)

Using RWE to Inform the Value and Affordability Assessment of Cell and Gene Therapies
Gladwell D, McQueen, R, Solà-Morales O, Richardson M

Workshop

Thursday, 15 May | 10:15 – 11:15 (ET)

Bridging the Credibility Gap: Establishing Competent and Reliable Scientific Evidence (CARSE) to Support Productive Healthcare Economic Information (HCEI) Discussions With US Payer Audiences
Lee J, Brixner D, Gillard K, Daw J

Posters

Wednesday, 14 May – Poster Session 1 | 10:30 – 13:30 (ET)

Trends in Indirect Treatment Comparison (ITC) Methods Used in Reimbursement Submissions in Canada and the US 
Emily Aiello, Tracy Westley, Kabir Toor

Wednesday, 14 May – Poster Session 2 | 16:00 – 19:00 (ET)

Maximizing the Impact of In-Trial Interviews Through AI Assisted Analysis
Martha Gauthier, Nathan Johnson, Ettya Fremont

Enhancing Early-Phase Trial Outcomes: The Value of Patient-Reported Treatment Tolerability
Blaise Cureg, Kathy Vong, Elizabeth Hribal, Nathan Johnson

Keeping With the Times: Emerging Methods for More Precise Survival Estimates to Inform Cost-Effectiveness Analysis
Yu-Heng Liu, Ioana Gulas, Emma Tyas, Yan-Zhi Tan, Amy Chang, Benjamin Kearns, Tracy Westley

Prognostic or Predictive Factors in Biliary Tract Cancer: A Systematic Literature Review
John Bridgewater, Juan Valle, Wayne Su, Javier Sabater, Sam Mettam, Lin Fan, Sally Bowditch, Amit Ahuja, Vijay Sharma, Suzy Paisley, Ankit Rohilla, Aikyadeep Mandal, Andrea Garcia, Farshid Dayyani, Richard Kim

Healthcare Resource Utilization and the Economic Burden of Neovascular Age-Related Macular Degeneration (nAMD): A Systematic Literature Review
Joelle A. Hallak, Inderpreet Khurana, Paul Oyefesobi, Vasudha Mukherjee, Tanya Madan, Francesca Cook, Joice T. Huang

Thursday, 15 May – Poster Session 3 | 10:30 – 13:30 (ET)

Evaluating the ICER Special Report in the Context of Medicare Drug Price Negotiations: Implications for Manufacturer Pricing and Evidence Strategies
Breyanne Bannister, Alissa Shaul, Jeff Lee, Jonathan Kowalski

Comparative Efficacy, Safety, and Tolerability of Xanomeline and Trospium Chloride versus Eight Atypical Antipsychotics for the Acute Treatment of Adults with Schizophrenia – A Network Meta-Analysis
Conor Hickey, Matthew Sidovar, Andrea Garcia, Kenneth Kramer, Amy Chang, Katrin Kupas, Vyshnavi Telukuntla, Andrew J. Cutler

Thursday, 15 May – Poster Session 4 | 16:00 – 19:00 (ET)

The Prevalence of Fractional-Polynomial Network Meta-analyses (fpNMAs) in Supporting Reimbursement Recommendations by Canada’s Drug Agency (CDA-AMC)
Emily Aiello, Ioana Gulas, Hollie Pilkington

Association Between Event-Free/Distant Relapse-Free Survival and Overall Survival in Patients With Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer
Aurelien Jamotte, Jagadeswara Rao Earla, Amin Haiderali, Amit Ahuja, Sakshi Jindal, Kanupriya Mahajan, Aniket Sharma, Ioana Gulas, Jane Candlish, Tracy Westley

Sex-Stratified Differences in Cardiac Interventions, Complications and Outcomes in the Netherlands Between 2018 and 2023
Katherine Styles, Nikita Jeswani, Anna Marza Florensa, Anna Newton, Josine Kuiper

A Systematic Literature Review of the Economic Burden in Patients with Ehlers-Danlos Syndrome in the United States
Amit Ahuja, Inderpreet Khurana, Rishabh Verma

Friday, 16 May – Poster Session 5 | 09:00 – 11:30 (ET)

Improving Patient Engagement Outcomes: A Pilot Study to Investigate the Role of Empathy in Scientific Writing
Martha Gauthier, Heather Nyce, Susan Daniels, Laura Watts

Development and Psychometric Validation of Patient-Reported Outcome Measures for Masseter Muscle Prominence (MMP): The Lower Facial Shape Questionnaire
Catherine Foley, Julia Garcia, Julie Whyte, Martha Gauthier, Brandon Foster, Elisabeth Lee, Vaishali Patel

Matching-Adjusted Indirect Comparison of Isatuximab-Bortezomib-Lenalidomide-Dexamethasone (IVRd) with Daratumumab-Lenalidomide-Dexamethasone (DRd) in Patients with Newly Diagnosed Multiple Myeloma Ineligible for Transplant
Feng Lin, Gaye Siliman, Emma Tyas, Richard Birnie, Jasmine Bradbury, Yu-Heng Liu, Lois Ratcliffe

Cost-Effectiveness of Pembrolizumab as Treatment for FIGO 2014 Stage III-IVA Cervical Cancer in the United States
Sarah Brand-Wiita, Chien-Jhih Tsai, Yu-Heng Liu, Izzy Thornton, Elizabeth Beaulieu, Dominic Muston, Elizabeth Szamreta, Karin Yamada, Linda Duska, Domenica Lorusso